United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin® LA in the Philippines
Mandaluyong, Philippines and Lausanne, Switzerland (ots/PRNewswire) - Pamorelin® one-, three- and six-month dosing option now available to patients in the Philippines United Laboratories Inc. (Unilab) and Debiopharm International SA (Debiopharm) announce the signature of an exclusive agreement for the distribution ...
mehr